Recall Register

Haemonetics Corporation: FDA recalls

Newest recall start date in this list: . TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034

FDA enforcement events from 2013 to 2022; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Haemonetics Corporation as the recalling firm in 8 events. The events have 31 product records. The recalls started from 2013 to 2022. All the events are device recalls. By FDA enforcement events, Haemonetics Corporation is number 442 of 1,629 firms that have a page. Events that Haemonetics Corporation started: none in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025. Class II is 100.0% of its events and 73.7% of all FDA events.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

8 events, newest first.

FDA enforcement events of Haemonetics Corporation
InitiatedProduct (first record)TypeClassRecordsStatus
26 Apr 2022TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034DeviceClass II1Terminated
19 Apr 2022Product Name: TEG5000 Analyzer (07-022, 07-033) with TEG Analytical Software (07-030, 07-031) and TEG Platelet Mapping Assay - PlateletMapping ADP & AA (07-014), PlateletMapping ADP (07-015), PlateletMapping AA (07-016). Issue occurs when Platelet Mapping Assay results from a TEG 5000 analyzer are viewed using TEG…DeviceClass II1Terminated
19 Feb 2020TEG Manager software versions used in conjunction with TEG 5000 are 1.1.0, 3.0.0, 4.0.0, 4.1.0 and 4.1.1. Intended: For in vitro coagulation studiesDeviceClass II1Terminated
21 Oct 2019CS5/5+ Fastpacks, 225 mL, 150¿ Res Autotransfusion Device - Product Usage: its related accessory components are intended to be used for the recovery and processing of blood shed during or subsequent to an operation or as a result of trauma.DeviceClass II22Terminated
13 Jul 2018Haemonetics OrthoPAT System-Integrated Set. Product Code: 1150H-00 OrthoPAT orthopedic perioperative autotransfusion system indicated for use to salvage RBCs from blood lost intraoperatively and postoperatively during surgical proceduresDeviceClass II2Terminated
2 Aug 2017Cell Saver 5/5+ Bowl Set, 70ml, Product ID: 0291E-00, 0291A-00 Indications for Use: The Haemonetics Cell Saver 5/5+ System and its related accessory components are intended to be used for the recovery and processing of blood shed during or subsequent to an operation or as a result of trauma.DeviceClass II2Terminated
26 Jan 2015Haemonetics TEG Hemostasis System Level II Control, Catalog number: 8002. Level II Control is a biological control for use with the Thrombelastograph (TEG) Hemostasis System.DeviceClass II1Terminated
20 Jun 2013TEG 5000 Thromboelastograph Coagulation Analyzer Product Usage: Multipurpose System for In Vitro Coagulation StudiesDeviceClass II1Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

Haemonetics Corporation: events for each product type
TypeEvents
Device8
Haemonetics Corporation: events in each class
ClassEvents
Class II8
Share of the events of the firm in Class I
0%
Share of all events on the register in Class I
18%
Events with the status Ongoing
0

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Haemonetics Corporation, by the year that the recall started. The largest year is 2022, with 2 events.

Official channels

Cite this page

Recall Register. Haemonetics Corporation: FDA recalls. https://recallregister.com/firm/haemonetics-corporation/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
MA

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Haemonetics Corporation have?
Class II: 8 events. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of Haemonetics Corporation?
FDA event 90323, which the firm started on 26 Apr 2022. The first product in the record is: TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034
How many FDA recalls of Haemonetics Corporation have the status Ongoing?
No event has the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.